Results 31 to 40 of about 13,203 (228)

The Effect of Corticosteroids on Post-Covid-19 Smell Loss: A Meta-Analysis [PDF]

Iranian Journal of Otorhinolaryngology, 2023
Introduction: The rate of olfactory loss related to COVID-19 was reported between 4-89 percent. There is no approved treatment for patients who experience anosmia after the mentioned infection.
Mona Kabiri, Maryam Emadzadeh
doaj   +1 more source

Olfactory Dysfunction and Dementia in Parkinson's Disease

Journal of Parkinson’s Disease, 2014
Dementia is one of the most debilitating symptoms of Parkinson's disease (PD), but the development of dementia is still difficult to predict at early stages of the disease. We recently found that hyposmia, one of the most typical non-motor features of PD,
Atsushi Takeda, Toru Baba, Akio Kikuchi, Takafumi Hasegawa, Naoto Sugeno, Masatoshi Konno, Emiko Miura, Etsuro Mori   +7 more
doaj   +1 more source

Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial

Trials, 2020
Objectives To assess the efficacy of local intranasal treatment with budesonide (nasal irrigation), in addition to olfactory rehabilitation, in the management of loss of smell in COVID-19 patients without signs of severity and with persistent hyposmia 30
Mary Daval, Alain Corré, Clement Palpacuer, Juliette Housset, Guillaume Poillon, Michael Eliezer, Benjamin Verillaud, Dorsaf Slama, Denis Ayache, Philippe Herman, Clement Jourdaine, Camille Hervé, Wissame El Bakkouri, Dominique Salmon, Charlotte Hautefort   +14 more
doaj   +1 more source

ANOSMIA IN COVID-19: UNDERLYING MECHANISMS AND ASSESSMENT OF AN OLFACTORY ROUTE TO BRAIN INFECTION (RUSSIAN TRANSLATION)

Juvenis Scientia, 2021
In recent months it has emerged that the novel coronavirus — responsible for the COVID-19 pandemic — causes reduction of smell and taste in a large fraction of patients.
R. Butowt, C. S. von Bartheld
doaj   +1 more source

COVID-19 induced hyposmia

, 2022
Hiposmija je simptom prepoznat kao jedan od najvažnijih simptoma SARS-CoV-2. Najčešće je prolazna, s povratom osjeta njuha nakon nekoliko dana ili tjedana te se razlikuje od istih povezanih s drugim virusima po svom iznenadnom nastanku i brzom oporavku.
Grgić, Mia
core  

Hyposmia in geriatric depression can be a meningioma

Journal of Geriatric Mental Health, 2019
Depression in the elderly population can be a manifestation of underlying neurological and systemic disorder. It can be harbinger in many neurological illnesses such as Parkinson's disease and Alzheimer's dementia.
Muruganandam Partheeban, Sundararajan Mathivanan   +1 more
doaj   +1 more source

Motor Deficits and Cerebellar Atrophy in Elovl5 Knock Out Mice

Frontiers in Cellular Neuroscience, 2017
Spino-Cerebellar-Ataxia type 38 (SCA38) is caused by missense mutations in the very long chain fatty acid elongase 5 gene, ELOVL5. The main clinical findings in this disease are ataxia, hyposmia and cerebellar atrophy.
Eriola Hoxha, Eriola Hoxha, Rebecca M. C. Gabriele, Ilaria Balbo, Francesco Ravera, Linda Masante, Vanessa Zambelli, Cristian Albergo, Nico Mitro, Donatella Caruso, Eleonora Di Gregorio, Alfredo Brusco, Barbara Borroni, Filippo Tempia, Filippo Tempia, Filippo Tempia   +15 more
doaj   +1 more source

Eosinophilic Upper Airway Inflammation in a Murine Model Using an Adoptive Transfer System Induces Hyposmia and Epithelial Layer Injury with Convex Lesions

Medical Sciences, 2019
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a refractory upper airway disease, accompanied mainly by eosinophilia and/or asthma. In addition, the disease correlates with a high rate of hyposmia, following a marked infiltration of ...
Akira Kanda, Kenji Kondo, Naoki Hosaka, Yoshiki Kobayashi, Dan Van Bui, Yasutaka Yun, Kensuke Suzuki, Shunsuke Sawada, Mikiya Asako, Akihiko Nakamura, Koichi Tomoda, Yoshiko Sakata, Koji Tsuta, David Dombrowicz, Hideyuki Kawauchi, Shigeharu Fujieda, Hiroshi Iwai   +16 more
doaj   +1 more source

A Two‐Stage Questionnaire and Actigraphy Screening for iRBD in a Multicenter Retrospective Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Isolated rapid‐eye‐movement sleep behavior disorder is a prodromal marker of synucleinopathies. However, most cases remain undiagnosed due to the insufficient predictive value of questionnaires and limited access to confirmatory video‐polysomnography. We assessed a two‐stage screening strategy combining a brief questionnaire on rapid‐
Caleb A. Massimi, Giorgio Ricciardiello Mejia, Andre Metzger, Kang Hyun Ryu, Salonee Marwaha, Eva Grzegorczyk, Li Zhou, Eliana Jacobs, Boris Gilyadov, Claudia Kunney, Liqhwa Ncube, Ankit Parekh, Emmanuel Mignot, Fanny M. Elahi, Joseph Winer, Kathleen Poston, Andreas Brink‐Kjaer, Emmanuel H. During   +17 more
wiley   +1 more source

Lost and Found: Is Olfactory Recovery More Promising After COVID‐19 Than Other Causes, Even 2 Years Later?

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Olfactory dysfunction is a hallmark feature of COVID‐19, yet the potential for recovery with long‐standing COVID‐19‐related smell loss (CRSL) remains uncertain, particularly when treatment is initiated years later. This study evaluated olfactory outcomes in patients with CRSL compared with non‐COVID‐19‐related smell loss (non‐CRSL),
John W. Hunsicker, Mabel Berg, Nicolaus Knight, Jessica W. Grayson, Bradford A. Woodworth, Justin H. Turner, Do‐Yeon Cho   +6 more
wiley   +1 more source